PREM14A

PRELIMINARY PROXY STATEMENT

Company: LISATA THERAPEUTICS, INC.
Filed: March 31, 2017
Period of Report: March 31, 2017
Accession Number: 0001571049-17-003097

View Document ↗ View on SEC.gov ↗